Replies to post #174208 on Vivos Inc (RDGL)

[Grig81]

It also wouldn’t be bad if they were doing it based on discussions / interest from institutional investors who want to invest directly with shares. The market cap of the company stays the same, there is no dilution, and the share price goes higher. Could be good to uplist and attract more investment. Regardless, that is at least 12-36 months away. The share price will increase tremendously after human trial data is released. We all know that the treatment WORKS, which is the most important aspect of all this

[mc73]

I would NEVER welcome a reverse split. Others here have been through one, yes, but those people also bought those orinal pre-split shares at a much lower cost.

Let's see how this plays out. 1st thing is first, IDE submission and approval.